Christopher Causey United Therapeutics Corp (UTHR) insider trading activity

UTHR Quotes by TradingView

Christopher Causey is of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 4,865 shares of UTHR, which is worth approximately $1.96 Million. The most recent transaction as insider was on Oct 22, 2020, when has been sold 2,500 shares (Common Stock) at a price of $63.9 per share, resulting in proceeds of $159,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.87K
32.38% 3M change
16.25% 12M change
Total Value Held $1.96 Million

CHRISTOPHER CAUSEY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 22 2020
BUY
Exercise of conversion of derivative security
$159,750 $63.9 p/Share
2,500 Added 42.92%
3,325 Common Stock
Oct 16 2020
SELL
Sale (or disposition) back to the issuer
$258,750 $115.0 p/Share
2,250 Reduced 73.17%
825 Common Stock
Oct 16 2020
BUY
Exercise of conversion of derivative security
$143,775 $63.9 p/Share
2,250 Added 49.18%
2,325 Common Stock
CC

Christopher Causey

Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on UTHR